Comparison between A B Infrabuild IPO and Earum Pharmaceuticals IPO.
IPO Details
A B Infrabuild IPO is a SME Fixed Price IPO proposed to list at NSE SME while Earum Pharmaceuticals IPO is a SME Fixed Price proposed to list at BSE SME.
Issue Size and Price
The total issue size of A B Infrabuild IPO is up to ₹12.19 Cr whereas the issue size of the Earum Pharmaceuticals IPO is up to ₹6.31 Cr. The final issue price of A B Infrabuild IPO is ₹29.00 per share and of Earum Pharmaceuticals IPO is ₹36.00 per share.
IPO Timetable
A B Infrabuild IPO opens on Jun 28, 2019, while Earum Pharmaceuticals IPO opens on Jun 21, 2019. The closing date of A B Infrabuild IPO and Earum Pharmaceuticals IPO is Jul 03, 2019, and Jun 26, 2019, respectively.
| | A B Infrabuild IPO | Earum Pharmaceuticals IPO |
|---|
| Issue Open | Jun 28, 2019 | Jun 21, 2019 |
| Issue Close | Jul 03, 2019 | Jun 26, 2019 |
| Basis Of Allotment (Tentative) | Jul 09, 2019 | Jul 01, 2019 |
| Initiation of Refunds (Tentative) | Jul 10, 2019 | Jul 02, 2019 |
| Credit of Share (Tentative) | Jul 10, 2019 | Jul 03, 2019 |
| Listing date (Tentative) | Jul 12, 2019 | Jul 04, 2019 |
Financials & KPIs
A B Infrabuild IPO P/E ratio is , as compared to Earum Pharmaceuticals IPO P/E ratio of .
Shares Offered
In the A B Infrabuild IPO Retail Individual Investors (RII) are offered 21,04,000 shares while in Earum Pharmaceuticals IPO retail investors are offered 21,04,000 shares. Qualified Institutional Buyers (QIB) are offered in A B Infrabuild IPO and in Earum Pharmaceuticals IPO.
| | A B Infrabuild IPO | Earum Pharmaceuticals IPO |
|---|
| Market Maker Reservation | 2,24,000 shares | 96,000 shares |
| NII | 21,00,000 shares | 8,76,000 shares |
| RII | 21,04,000 shares | 8,76,000 shares |
| Total | 42,04,000 shares | 17,52,000 shares |
Bids Received (Subscription)
A B Infrabuild IPO subscribed 0.97x in total, whereas Earum Pharmaceuticals IPO subscribed 1.60x.
